tirzepatide chronic kidney disease (Zepbound) showed improved function in obese patients with both kidney and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Tirzepatide improves kidney outcomes in

The weight change at one year post-discontinuation was small, but depended heavily on the individual and may partly reflect the fact that many patients resumed or transitioned to other weight-management therapies rather than remaining untreated

Researchers have proposed several mechanisms, including direct effects on gene transcription factors and indirect influences through cellular signaling cascades that regulate telomerase activity

By Nancy Lapid June 8 (Reuters) - Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis suggests

J Clin Invest (2007) 117:3393402.10.1172/JCI31547 51 DanielyanLKleinRHansonLRBuadzeMSchwabMGleiterCHet alProtective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease

What the researchers discovered was that there was no elevation in PMS symptoms and breast tenderness with caffeine intake from coffee